Cutting Medicare Prescription Drug Prices in Half Act

Bill 118 s 1450, also known as the Cutting Medicare Prescription Drug Prices in Half Act, is a piece of legislation introduced in the US Congress. The main goal of this bill is to reduce the cost of prescription drugs for Medicare beneficiaries by half.

The bill proposes several measures to achieve this goal. One key provision is to allow Medicare to negotiate drug prices directly with pharmaceutical companies. Currently, Medicare is prohibited from negotiating drug prices, which can result in higher costs for beneficiaries. By allowing negotiation, the government hopes to lower prices and make medications more affordable for seniors.

Additionally, the bill aims to increase transparency in drug pricing by requiring pharmaceutical companies to disclose the costs of research and development, as well as the prices charged for drugs in other countries. This information would help policymakers and consumers better understand the factors contributing to high drug prices in the US. Furthermore, the Cutting Medicare Prescription Drug Prices in Half Act seeks to cap out-of-pocket costs for Medicare beneficiaries at $2,000 per year. This would provide financial relief for seniors who struggle to afford their medications due to high co-pays and deductibles. Overall, the bill is designed to address the issue of rising prescription drug prices and make medications more affordable for Medicare beneficiaries. Supporters argue that these measures would help reduce healthcare costs for seniors and improve access to essential medications. Critics, however, raise concerns about the potential impact on pharmaceutical companies and the broader healthcare industry.